Mitochondria on the move: Horizontal mitochondrial transfer in disease and health

0571547 - BTÚ 2024 RIV US eng J - Článek v odborném periodiku
Dong, L. - Rohlena, Jakub - Zobalová, Renata - Nahácka, Zuzana - Rodriguez, A. - Berridge, M. V. V. - Neužil, Jiří
Mitochondria on the move: Horizontal mitochondrial transfer in disease and health.
Journal of Cell Biology. Roč. 222, č. 3 (2023), č. článku e202211044. ISSN 0021-9525. E-ISSN 1540-8140
Grant CEP: GA ČR(CZ) GA20-05942S; GA ČR(CZ) GX21-04607X; GA ČR(CZ) GA22-34507S; GA ČR(CZ) GA22-34507S; GA MZd(CZ) NU22-08-00160
Institucionální podpora: RVO:86652036
Klíčová slova: MESENCHYMAL STEM-CELLS * MULTIPOTENT STROMAL CELLS * TUNNELING NANOTUBES
Obor OECD: Cell biology
Impakt faktor: 7.8, rok: 2022
Způsob publikování: Open access
https://rupress.org/jcb/article/222/3/e202211044/213873/Mitochondria-on-the-move-Horizontal-mitochondrial

Jiri Neuzil and colleagues review the processes and mechanisms that underlie horizontal mitochondrial transfer (HMT) and the metabolic consequences of HMT in cells. Mammalian genes were long thought to be constrained within somatic cells in most cell types. This concept was challenged recently when cellular organelles including mitochondria were shown to move between mammalian cells in culture via cytoplasmic bridges. Recent research in animals indicates transfer of mitochondria in cancer and during lung injury in vivo, with considerable functional consequences. Since these pioneering discoveries, many studies have confirmed horizontal mitochondrial transfer (HMT) in vivo, and its functional characteristics and consequences have been described. Additional support for this phenomenon has come from phylogenetic studies. Apparently, mitochondrial trafficking between cells occurs more frequently than previously thought and contributes to diverse processes including bioenergetic crosstalk and homeostasis, disease treatment and recovery, and development of resistance to cancer therapy. Here we highlight current knowledge of HMT between cells, focusing primarily on in vivo systems, and contend that this process is not only (patho)physiologically relevant, but also can be exploited for the design of novel therapeutic approaches.
Trvalý link: https://hdl.handle.net/11104/0343553